Consistently, our study presents evidence that mRNA and protein expressions of CD44 were elevated in ccRCC tissues, in line with our analysis of TCGA-KIRC and CPTAC databases. This evidence concerns the gene CD44 and nonpapillary renal cell carcinoma.